{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05579366",
            "orgStudyIdInfo": {
                "id": "PRO1184-001"
            },
            "secondaryIdInfos": [
                {
                    "id": "CTR20230813",
                    "type": "REGISTRY",
                    "domain": "Chinadrugtrials.org.cn"
                },
                {
                    "id": "GCT1184-01",
                    "type": "OTHER",
                    "domain": "Genmab"
                }
            ],
            "organization": {
                "fullName": "ProfoundBio US Co.",
                "class": "INDUSTRY"
            },
            "briefTitle": "PRO1184 for Advanced Solid Tumors",
            "officialTitle": "Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors",
            "acronym": "PRO1184-001",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "for-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-12-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-10-04",
            "studyFirstSubmitQcDate": "2022-10-11",
            "studyFirstPostDateStruct": {
                "date": "2022-10-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ProfoundBio US Co.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors.\n\nParticipants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable).",
            "detailedDescription": "This is a Phase 1/2 study of PRO1184, a folate receptor alpha (FR\u03b1) targeted antibody-drug conjugate, to evaluate the safety, tolerability, PK, and antitumor activity of PRO1184 in participants with selected locally advanced and/or metastatic solid tumors, including epithelial ovarian cancer, endometrial cancer, breast cancer, non-small cell lung cancer, and mesothelioma.\n\nThe study consists of 4 main parts:\n\nPart A: dose-escalation cohorts\n\nPart B: tumor-specific monotherapy dose-expansion cohorts\n\nPart C: platinum-resistant ovarian cancer (PROC) cohort\n\nPart D: combination therapy cohorts\n\nParticipants will continue to receive study treatment until the first instance of disease progression, unacceptable toxicity, investigator decision, consent withdrawal, study termination by the Sponsor, pregnancy, or death."
        },
        "conditionsModule": {
            "conditions": [
                "Platinum-Resistant Ovarian Cancer",
                "Platinum Sensitive Ovarian Cancer (PSOC)",
                "High Grade Epithelial Ovarian Cancer",
                "High Grade Serous Ovarian Cancer",
                "Primary Peritoneal Carcinoma",
                "Fallopian Tube Cancer",
                "Endometrial Cancer",
                "Non-small Cell Lung Cancer",
                "Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)",
                "Mesothelioma",
                "Breast Adenocarcinoma",
                "Triple Negative Breast Cancer",
                "Hormone Receptor-positive/Her2 Negative Breast Cancer"
            ],
            "keywords": [
                "antibody-drug conjugate",
                "folate receptor alpha",
                "folate receptor",
                "solid tumor",
                "ovarian cancer",
                "primary peritoneal carcinoma",
                "fallopian tube cancer",
                "endometrial cancer",
                "non-small cell lung cancer",
                "mesothelioma",
                "breast cancer",
                "triple negative breast cancer",
                "HR+/HER2- breast cancer",
                "topoisomerase I inhibitor",
                "PROC",
                "EGFR-mutated NSCLC"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Participants will receive PRO1184 in ascending dose levels to establish a maximum tolerated dose, if reached, and the recommended Phase 2 dose, followed by dose expansion at selected dose and schedule.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 354,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part A, B, C",
                    "type": "EXPERIMENTAL",
                    "description": "PRO1184 monotherapy in escalating doses in Part A and at the recommended dose in Part B and C.",
                    "interventionNames": [
                        "Drug: PRO1184"
                    ]
                },
                {
                    "label": "Part D1",
                    "type": "EXPERIMENTAL",
                    "description": "PRO1184 in combination with carboplatin",
                    "interventionNames": [
                        "Drug: PRO1184 intravenous infusion of PRO1184"
                    ]
                },
                {
                    "label": "Part D2",
                    "type": "EXPERIMENTAL",
                    "description": "PRO1184 in combination with bevacizumab",
                    "interventionNames": [
                        "Drug: PRO1184 intravenous infusion of PRO1184"
                    ]
                },
                {
                    "label": "Part D3",
                    "type": "EXPERIMENTAL",
                    "description": "PRO1184 in combination with pembrolizumab",
                    "interventionNames": [
                        "Drug: PRO1184 intravenous infusion of PRO1184"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "PRO1184",
                    "description": "Intravenous infusion of PRO1184",
                    "armGroupLabels": [
                        "Part A, B, C"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "PRO1184 intravenous infusion of PRO1184",
                    "description": "Carboplatin intravenous infusion",
                    "armGroupLabels": [
                        "Part D1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "PRO1184 intravenous infusion of PRO1184",
                    "description": "Bevacizumab intravenous infusion",
                    "armGroupLabels": [
                        "Part D2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "PRO1184 intravenous infusion of PRO1184",
                    "description": "Pembrolizumab intravenous infusion",
                    "armGroupLabels": [
                        "Part D3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Parts A, B, and D - Incidence of Treatment-Emergent Adverse Events (TEAEs) [Safety and Tolerability]",
                    "description": "Type, incidence, severity, and seriousness of adverse events",
                    "timeFrame": "Through end of treatment, up to approximately 1 year."
                },
                {
                    "measure": "Parts A, and D - Dose Limiting Toxicity (DLT)",
                    "description": "The proportion of participants experiencing (DLT).",
                    "timeFrame": "At the end of Cycle 1 (each cycle is 21 days)"
                },
                {
                    "measure": "Parts A, B, and D - Type, Incidence, and Severity of Laboratory Abnormalities",
                    "timeFrame": "Through end of treatment, up to approximately 1 year."
                },
                {
                    "measure": "Part C - Objective Response Rate (ORR) as Assessed by Blinded Independent Central Review (BICR) per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1",
                    "timeFrame": "Through end of treatment, up to approximately 1 year."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Parts A, B, and D - Best Overall Response (BOR)",
                    "description": "Best response as assessed by the investigator per RECIST v1.1 criteria for all tumor types other than pleural mesothelioma which will use mRECIST v1.1.",
                    "timeFrame": "Up to approximately 1 year."
                },
                {
                    "measure": "Parts A, B, and D - ORR",
                    "description": "Participants who achieve partial or complete response per RECIST v1.1 criteria.",
                    "timeFrame": "Up to approximately 1 year."
                },
                {
                    "measure": "Parts A, B, and D - Disease Control Rate (DCR)",
                    "description": "Participants who achieve stable disease, partial or complete response per RECIST v1.1 criteria.",
                    "timeFrame": "Up to approximately 1 year."
                },
                {
                    "measure": "Parts A, B, C, and D - Progression-Free Survival (PFS)",
                    "description": "Time from start of treatment to first documented disease progression or death",
                    "timeFrame": "Through end of treatment, up to approximately 1 year."
                },
                {
                    "measure": "Part C - Overall survival (OS)",
                    "description": "Time from the start of study treatment to the date of death from any cause",
                    "timeFrame": "Up to approximately 2 years."
                },
                {
                    "measure": "Parts A, B, C, and D - Duration of Objective Response (DOR)",
                    "description": "Time from the first documentation of an objective tumor response (CR or PR) to the first documented tumor progression or death",
                    "timeFrame": "From date of enrollment until the date of first documented disease progression or date of study withdrawal, whichever came first, assessed up to 12 months."
                },
                {
                    "measure": "Parts A, B, and D - Peak Plasma Concentration (Cmax) for PRO1184",
                    "description": "Measurement of maximum plasma concentration after the administration of PRO1184.",
                    "timeFrame": "Through end of treatment, up to approximately 1 year."
                },
                {
                    "measure": "Parts A, B, and D - Area under the Plasma Concentration Versus Time Curve (AUC) for PRO1184",
                    "description": "Measurement of AUC after the administration of PRO1184.",
                    "timeFrame": "Through end of treatment, up to approximately 1 year."
                },
                {
                    "measure": "Time to Reach Cmax (Tmax) for PRO1184",
                    "timeFrame": "Through end of treatment, up to approximately 1 year"
                },
                {
                    "measure": "Trough Concentrations (Ctrough) for PRO1184",
                    "timeFrame": "Through end of treatment, up to approximately 1 year"
                },
                {
                    "measure": "Apparent Terminal Half-life (t1/2) for PRO1184",
                    "timeFrame": "Through end of treatment, up to approximately 1 year"
                },
                {
                    "measure": "Parts C and D - CA-125 Response Determined Using the Gynecologic Cancer Intergroup (GCIG) Criteria",
                    "timeFrame": "Through end of treatment, up to approximately 1 year"
                },
                {
                    "measure": "Part C - Type, Incidence, Severity, Seriousness as per Common Terminology Criteria for Adverse Events (CTCAE) v5.0, and Relatedness of Adverse Events (AEs)",
                    "timeFrame": "Through end of treatment, up to approximately 1 year"
                },
                {
                    "measure": "Part C - Type, Incidence, and Severity of Laboratory Abnormalities",
                    "timeFrame": "Through end of treatment, up to approximately 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nPart A and B:\n\n* Histologically or cytologically confirmed metastatic or unresectable solid malignancy including ovarian cancer (must have epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer), endometrial cancer, non-small cell lung cancer (Part A), EGFR-mutated NSCLC (Part B), breast cancer (hormone receptor positive, HER2-negative and triple-negative) (Part A), mesothelioma.\n* Previously received therapies known to confer clinical benefit.\n* Willing to provide a tumor sample (archive tissue or fresh biopsy).\n* Eastern cooperative oncology group (ECOG) performance status 0 or 1.\n* Measurable disease per RECIST v1.1 for all tumor types other than pleural mesothelioma which will use mRECIST v1.1 at baseline.\n* Adequate hematologic, hepatic, renal and cardiac function.\n\nPart C:\n\nHigh grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer (excluding endometrioid, clear cell carcinomas, mucinous, low grade, and those with a sarcomatous or neuroendocrine element)\n\n* Participants must have received 1 to 3 lines of therapy.\n* Participants must have platinum-resistant/refractory ovarian cancer.\n* Participants must have received prior bevacizumab.\n* Participants with known or suspected deleterious germline or somatic BRCA mutations (as determined by FDA-approved test in a CLIA-certified laboratory) must have been treated with a poly ADP-ribose polymerase (PARP) inhibitor.\n* Participants must have known FR\u03b1 status based on an FDA approved test (the Ventana FOLR1 RxDx Assay). Those who are FR\u03b1 positive must have previously received mirvetuximab soravtansine, (MIRV), unless the patient has a documented medical exception.\n* Prior induction plus maintenance is considered 1 line of therapy, even if parts of the treatment regimen (induction or maintenance) are interrupted and/or resumed at a later date, in the absence of disease progression while on active treatment.\n* A switch/change in regimen due solely to toxicity or participant preference (and not disease progression) is not considered a separate line of therapy.\n\nPart D:\n\nCohort D1 (PRO1184+carboplatin):\n\n* Participants must have platinum-sensitive ovarian cancer.\n* Participants must have received 1 to 3 prior lines of therapy.\n\nCohort D2 (PRO1184+bevacizumab):\n\n* Participants must have platinum-resistant/refractory ovarian cancer.\n* Patients must have received 1 to 2 prior lines of therapy.\n\nCohort D3 (PRO1184+pembrolizumab):\n\n* Endometrial cancer (any subtype excluding sarcoma).\n* Participants must have received prior platinum-based chemotherapy for recurrent or advanced disease.\n\nExclusion Criteria:\n\n* Other malignancy within 3 years.\n* Active central nervous system (CNS) metastases (treated, stable CNS metastases are allowed).\n* Uncontrolled Grade 3 or greater infection within 2 weeks.\n* Positive for HBV, HCV or human immunodeficiency virus (HIV).\n* History of (non-infectious) interstitial lung disease (ILD)/pneumonitis that required steroids within the past 2 years, has current ILD/pneumonitis, or where suspected ILD/pneumonitis cannot be ruled out by imaging at screening.\n* Use of a strong CYP3A inhibitor within 14 days (dose escalation only).\n* Prior therapy with a topoisomerase 1 inhibitor-based antibody drug conjugate.\n\nNote: Other protocol-defined inclusion/exclusion may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Genmab Trial Information",
                    "role": "CONTACT",
                    "phone": "+4570202728",
                    "email": "clinicaltrials@genmab.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Official",
                    "affiliation": "Genmab",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "USOR HonorHealth",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "USOR Arizona Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85711",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "University of California Los Angeles Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California, San Diego; Moores Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "USOR Sansum Clinic",
                    "status": "RECRUITING",
                    "city": "Santa Barbara",
                    "state": "California",
                    "zip": "93105",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.42083,
                        "lon": -119.69819
                    }
                },
                {
                    "facility": "Providence Medical Foundation",
                    "status": "RECRUITING",
                    "city": "Santa Rosa",
                    "state": "California",
                    "zip": "95403",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.44047,
                        "lon": -122.71443
                    }
                },
                {
                    "facility": "USOR Florida Cancer Specialists South",
                    "status": "RECRUITING",
                    "city": "Fort Myers",
                    "state": "Florida",
                    "zip": "33908",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.62168,
                        "lon": -81.84059
                    }
                },
                {
                    "facility": "USOR Florida Cancer Specialists North",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "state": "Florida",
                    "zip": "33709",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.77086,
                        "lon": -82.67927
                    }
                },
                {
                    "facility": "USOR Florida Cancer Specialists East",
                    "status": "RECRUITING",
                    "city": "West Palm Beach",
                    "state": "Florida",
                    "zip": "33401",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.71534,
                        "lon": -80.05337
                    }
                },
                {
                    "facility": "University of Kansas Medical Center (KUMC)",
                    "status": "RECRUITING",
                    "city": "Westwood",
                    "state": "Kansas",
                    "zip": "66205",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.04056,
                        "lon": -94.6169
                    }
                },
                {
                    "facility": "USOR Maryland Oncology Hematology",
                    "status": "RECRUITING",
                    "city": "Rockville",
                    "state": "Maryland",
                    "zip": "20850",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.084,
                        "lon": -77.15276
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48085",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "START Midwest",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49503",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "USOR Minnesota Oncology Hematology",
                    "status": "RECRUITING",
                    "city": "Maplewood",
                    "state": "Minnesota",
                    "zip": "55109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.95302,
                        "lon": -92.99522
                    }
                },
                {
                    "facility": "University of Oklahoma - Health Sciences Center",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "Women and Infants Hospital of Rhode Island",
                    "status": "RECRUITING",
                    "city": "Providence",
                    "state": "Rhode Island",
                    "zip": "02905",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.82399,
                        "lon": -71.41283
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute at Tennessee Oncology",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "USOR Texas Oncology",
                    "status": "RECRUITING",
                    "city": "Abilene",
                    "state": "Texas",
                    "zip": "79606",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.44874,
                        "lon": -99.73314
                    }
                },
                {
                    "facility": "Mary Crowley Cancer Research",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75521",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "USOR Texas Oncology",
                    "status": "RECRUITING",
                    "city": "Fort Worth",
                    "state": "Texas",
                    "zip": "76104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.72541,
                        "lon": -97.32085
                    }
                },
                {
                    "facility": "USOR Texas Oncology Gulf Coast",
                    "status": "RECRUITING",
                    "city": "Woodland",
                    "state": "Texas",
                    "zip": "77380",
                    "country": "United States"
                },
                {
                    "facility": "START Mountain Region",
                    "status": "RECRUITING",
                    "city": "West Valley City",
                    "state": "Utah",
                    "zip": "84119",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.69161,
                        "lon": -112.00105
                    }
                },
                {
                    "facility": "USOR Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "USOR Virginia Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "Cancer hospital, Chinese Academy of Medical Sciences",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "state": "Beijing",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Hunan Cancer Hospital - Phase 1",
                    "status": "RECRUITING",
                    "city": "Changsha",
                    "state": "Hunan",
                    "country": "China",
                    "geoPoint": {
                        "lat": 28.19874,
                        "lon": 112.97087
                    }
                },
                {
                    "facility": "Hunan Cancer Hospital - Thoracic Medicine Dept II",
                    "status": "RECRUITING",
                    "city": "Changsha",
                    "state": "Hunan",
                    "country": "China",
                    "geoPoint": {
                        "lat": 28.19874,
                        "lon": 112.97087
                    }
                },
                {
                    "facility": "Jilin Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Chang chun",
                    "state": "Jilin",
                    "country": "China",
                    "geoPoint": {
                        "lat": 42.74694,
                        "lon": 126.24667
                    }
                },
                {
                    "facility": "Fudan University Shanghai Cancer Center - Gynecologic Oncology",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Fudan University Shanghai Cancer Center- Phase 1",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                },
                {
                    "id": "D000010051",
                    "term": "Ovarian Neoplasms"
                },
                {
                    "id": "D000077216",
                    "term": "Carcinoma, Ovarian Epithelial"
                },
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000064726",
                    "term": "Triple Negative Breast Neoplasms"
                },
                {
                    "id": "D000008654",
                    "term": "Mesothelioma"
                },
                {
                    "id": "D000086002",
                    "term": "Mesothelioma, Malignant"
                },
                {
                    "id": "D000005185",
                    "term": "Fallopian Tube Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000010049",
                    "term": "Ovarian Diseases"
                },
                {
                    "id": "D000000291",
                    "term": "Adnexal Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000006058",
                    "term": "Gonadal Disorders"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000000236",
                    "term": "Adenoma"
                },
                {
                    "id": "D000018301",
                    "term": "Neoplasms, Mesothelial"
                },
                {
                    "id": "D000010997",
                    "term": "Pleural Neoplasms"
                },
                {
                    "id": "D000005184",
                    "term": "Fallopian Tube Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12974",
                    "name": "Ovarian Neoplasms",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30373",
                    "name": "Triple Negative Breast Neoplasms",
                    "asFound": "Triple Negative Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1704",
                    "name": "Carcinoma, Ovarian Epithelial",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11634",
                    "name": "Mesothelioma",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2537",
                    "name": "Mesothelioma, Malignant",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8328",
                    "name": "Fallopian Tube Neoplasms",
                    "asFound": "Fallopian Tube Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12972",
                    "name": "Ovarian Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3643",
                    "name": "Adnexal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9163",
                    "name": "Gonadal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3591",
                    "name": "Adenoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20445",
                    "name": "Neoplasms, Mesothelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M13887",
                    "name": "Pleural Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8327",
                    "name": "Fallopian Tube Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4352",
                    "name": "Ovarian Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4354",
                    "name": "Ovarian Epithelial Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2189",
                    "name": "Fallopian Tube Cancer",
                    "asFound": "Fallopian Tube Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3584",
                    "name": "Malignant Mesothelioma",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M18650",
                    "name": "Carboplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "relevance": "LOW"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M246",
                    "name": "Bevacizumab",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M29349",
                    "name": "Topoisomerase I Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}